These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 19504468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment for seasonal allergic rhinitis by Chinese herbal medicine: a randomized placebo controlled trial.
    Xue CC, Thien FC, Zhang JJ, Da Costa C, Li CG.
    Altern Ther Health Med; 2003; 9(5):80-7. PubMed ID: 14526714
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis.
    Saxena VS, Venkateshwarlu K, Nadig P, Barbhaiya HC, Bhatia N, Borkar DM, Gill RS, Jain RK, Katiyar SK, Nagendra Prasad KV, Nalinesha KM, Nasiruddin K, Rishi JP, Roy Chowdhury J, Saharia PS, Thomas B, Bagchi D.
    Int J Clin Pharmacol Res; 2004; 24(2-3):79-94. PubMed ID: 15689054
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 6. Butterbur Ze339 for the treatment of intermittent allergic rhinitis: dose-dependent efficacy in a prospective, randomized, double-blind, placebo-controlled study.
    Schapowal A, Petasites Study Group.
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1381-6. PubMed ID: 15611396
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

  • 8. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G.
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [Abstract] [Full Text] [Related]

  • 9. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV, Hamelmann E, Zielen S, Kamin W, Bergmann KC, Sieder C, Stenglein S, Seyfried S, Wahn U, DUAL study group.
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [Abstract] [Full Text] [Related]

  • 10. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial.
    de Blic J, Wahn U, Billard E, Alt R, Pujazon MC.
    Pediatr Allergy Immunol; 2005 May; 16(3):267-75. PubMed ID: 15853959
    [Abstract] [Full Text] [Related]

  • 11. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A.
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [Abstract] [Full Text] [Related]

  • 12. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
    Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C, Faris MA, Ellsworth A, Caldwell MF.
    Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
    [Abstract] [Full Text] [Related]

  • 13. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
    Berkowitz RB, McCafferty F, Lutz C, Bazelmans D, Godfrey P, Meeves S, Liao Y, Georges G.
    Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
    Ratner PH, van Bavel JH, Martin BG, Hampel FC, Howland WC, Rogenes PR, Westlund RE, Bowers BW, Cook CK.
    J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ, Powell RJ, Corrigan CJ, Durham SR, UK Immunotherapy Study Group.
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [Abstract] [Full Text] [Related]

  • 16. Treating intermittent allergic rhinitis: a prospective, randomized, placebo and antihistamine-controlled study of Butterbur extract Ze 339.
    Schapowal A, Study Group.
    Phytother Res; 2005 Jun; 19(6):530-7. PubMed ID: 16114089
    [Abstract] [Full Text] [Related]

  • 17. Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life.
    Alvarez-Cuesta E, Aragoneses-Gilsanz E, Martín-Garcia C, Berges-Gimeno P, Gonzalez-Mancebo E, Cuesta-Herranz J.
    Clin Exp Allergy; 2005 May; 35(5):572-8. PubMed ID: 15898977
    [Abstract] [Full Text] [Related]

  • 18. Treatment of perennial allergic rhinitis using Shi-Bi-Lin, a Chinese herbal formula.
    Zhao Y, Woo KS, Ma KH, van Hansselt CA, Wong KC, Cheng KF, Lam CW, Leung PC.
    J Ethnopharmacol; 2009 Feb 25; 122(1):100-5. PubMed ID: 19118617
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
    Mirone C, Albert F, Tosi A, Mocchetti F, Mosca S, Giorgino M, Pecora S, Parmiani S, Ortolani C.
    Clin Exp Allergy; 2004 Sep 25; 34(9):1408-14. PubMed ID: 15347374
    [Abstract] [Full Text] [Related]

  • 20. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM, Serra-Batlles J, Meseguer J, Castillo JA, De Molina M, Valero A, Picado C, Rupatadine Study Group.
    Allergy; 2004 Jul 25; 59(7):766-71. PubMed ID: 15180765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.